TrialHuman vaccines & immunotherapeutics2018

Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.

Won Suk Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.